Skip to Content
Merck

Skip To

SML4149

Gliocidin

≥98% (HPLC), powder, IMPDH2 Inhibitor

Synonym(s):

N-3-Pyridinyl-2-thiophenecarboxamide, SW106065

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Size/SKUAvailabilityPrice

About This Item

Empirical Formula (Hill Notation):
C10H8N2OS
CAS Number:
Molecular Weight:
204.25
MDL number:
NACRES:
NA.21
UNSPSC Code:
12352200
Assay:
≥98% (HPLC)
Form:
powder
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

SMILES string

O=C(C1=CC=CS1)NC2=CC=CN=C2

Application

Gliocidin may be used to investigate its effects on glioblastoma by inhibiting cell proliferation and regulating metabolic pathways. It may also be used to induce tumor cell death in glioblastoma by targeting the de novo purine synthesis pathway through the indirect inhibition of inosine monophosphate dehydrogenase 2 (IMPDH2).

Biochem/physiol Actions

Gliocidin is a potent and low-toxic BBB-permeable prodrug that targets glioblastoma by depleting guanylates via IMPDH2 inhibition; enhances effects with temozolomide. Gliocidin, a nanomolar-potent prodrug (IC50 ~9.17 nM under Nam-depleted conditions), inhibits IMPDH2, disrupting guanine nucleotide synthesis, which is crucial for tumor DNA and RNA production. Activated via the NAD+ salvage pathway into gliocidin-adenine dinucleotide (9-AD), it selectively depletes guanylate in tumor cells, leading to cell death. Gliocidin demonstrates effective blood-brain barrier penetration (brain/plasma ratio ~7.75) and significantly reduces glioblastoma growth in vivo at 50 mg/kg intraperitoneally, twice daily, without observed toxicity. Sensitivity to nicotinamide levels (IC50 increases to 35.7 μM with 1 mM Nam) underscores its pathway dependence. Combined with temozolomide (50 mg/kg/day), gliocidin′s efficacy improves through NMNAT1 upregulation, enhancing 9-AD formation and maintaining a strong safety profile. Gliocidin is known to modulate mTOR complex 1 (mTORC1) signaling and impact purine metabolism.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
SCC289WH0003615M1SCC282
description

≥98% (HPLC), powder, IMPDH2 Inhibitor

description

SF295 human glioblastoma cell line is a valuable model for glioblastoma research.

description

clone 1E12-B6, purified immunoglobulin, buffered aqueous solution

description

SF188 human glioblastoma cell line is an important cellular model for pediatric human glioblastoma.

form

powder

form

-

form

buffered aqueous solution

form

-

assay

≥98% (HPLC)

assay

-

assay

-

assay

-

Quality Level

100

Quality Level

-

Quality Level

100

Quality Level

-

storage temp.

-10 to -25°C

storage temp.

-

storage temp.

−20°C

storage temp.

-

solubility

DMSO: 2 mg/mL, clear

solubility

-

solubility

-

solubility

-

color

white to beige

color

-

color

-

color

-


Storage Class

11 - Combustible Solids

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library